About
Christophe Bancel is based out of Paris, Ile-de-France and is the Chief Executive Officer and Director at TISSIUM. Most recently, Christophe was Franchise General Manager at UCB, leading the Central Nervous System Operations in France. Prior to that, he held several corporate and strategic positions at UCB, including Pricing and Markets Access in the US (Atlanta, GA), Global Marketing (Brussels) and Patient & Market Insight (Brussels). He also worked for Serono in multiple Sales and Marketing positions. He started his career in Biotech, as Business Developer at Transgene and then was a co-founder and Director of Corporate & Business Development at Faust Pharmaceuticals (now Domain Therapeutics). Christophe is a graduate from Ecole Centrale Paris (Master of Engineering), holds a Master in Biochemistry and Molecular Biology from the University of Tokyo (Todaï) and an MBA from INSEAD.Since 2012, he is a member of the iBionext Network.
Position in the VCSift Database
- • 2 investors at TISSIUM are tracked.
- • 1,913 investors hold the Founder & CEO role in VCSift. Christophe Bancel is one of them.
- • 2,833 investors are based in Paris, Ile-de-France, France.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Location
- Paris, France
Contact Information
Find more investors like Christophe
Search Investors